Waltham’s Dynatrace raises $4 Million January 17, 2011
Posted by hubtechinsider in Startups, Venture Capital.Tags: Add-on (Mozilla), AJAX, dynaTrace software, Internet Explorer, JavaScript, waltham, Waltham Massachusetts
add a comment
Waltham’s Dynatrace , a provider of application performance management software, raises $4 Million from a group of undisclosed investors.
Related Articles
- DynaTrace Drums Up $4M (xconomy.com)
- $12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals (xconomy.com)
- Magen Biosciences, a Waltham, MA-based company focused on novel dermatology treatments, is acquired by the contract research firm PPD for $14.5 million (hubtechinsider.wordpress.com)
- New Hands On Demo Video of dynaTrace AJAX Edition 2.0 available (dynatrace.com)
- dynaTrace at Web Performance Meetups in Boston and New York City (dynatrace.com)
- Sneak Peak on Firefox support with dynaTrace (dynatrace.com)
- Antivirus Add-On for IE to cause 5 times slower page load times (dynatrace.com)
Magen Biosciences, a Waltham, MA-based company focused on novel dermatology treatments, is acquired by the contract research firm PPD for $14.5 million December 18, 2010
Posted by hubtechinsider in Acquisitions, Biotech, Health Care IT, Pharmaceuticals, Startups.Tags: Acquisitions, Biotech, Biotechnology, Christoph Westphal, Health Care IT, IDG Ventures, Magen Biosciences, Massachusetts General Hospital, pharmaceuticals, PPD, Sirtris Pharmaceuticals, Startups, TVM Capital, waltham, Waltham Massachusetts
add a comment
Magen Biosciences, a Waltham, MA-based company focused on novel dermatology treatments, will be acquired by the contract research firm PPD for $14.5 million. The firm was founded in 2006 by a well known group of biotech entrepreneuers and investors, including Rich Aldrich, founder of RA Capital, David Fisher, chief of dermatology at Massachusetts General Hospital, and Christoph Westphal, co-founder of Sirtris Pharmaceuticals. Having raised $17 million in seed and Series A financing from a syndicate of backers including ARCH Venture Partners, TVM Capital, and IDG Ventures (now Flybridge Capital Partners), the purchase price is unlikely to result in an exit for Magen’s backers.
Back in 2008, Magen inlicensed for an undisclosed sum a number of derm compounds from Eli Lilly that showed positive anti-inflammatory and anti-proliferative results in preclinical studies. It’s a good thing they did: those compounds were the primary reason for PPD’s interest in the biotech. The buy-out gives PPD an entrée into the specialist field of dermatology. In a press release announcing the news, PPD CEO Fred Eshelman noted that dermatologic treatments generally have a “more straightforward path to regulatory approval.” That’s certainly part of the logic behind moves of another specialist drug maker, Valeant, which is trying to brand itself as a derm power-house thanks to the recent acquisitions of Coria Laboratories, Dow, and DermaTech.
Related Articles
- PPD Sets Record and Distribution Dates for Spin-Off of Furiex Pharmaceuticals (eon.businesswire.com)
- More Downsizing (biojobblog.com)
- DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News (xconomy.com)
- PPD Opens New Office in Beijing, China (eon.businesswire.com)
Novartis Option Fund leads a $30 million Series B financing round for Waltham’s Avila Therapeutics December 18, 2010
Posted by hubtechinsider in Startups, Venture Capital.Tags: Business, Dana–Farber Cancer Institute, Doctor of Philosophy, Novartis Option Fund, Polaris Venture Partners, Protein, Series A round, Startups, Venture Capital, waltham, Waltham Massachusetts
1 comment so far
Novartis Option Fund leads a $30 million Series B financing round for Waltham’s Avila Therapeutics.
In a deal that combines equity financing with an option on an early-stage research program, Novartis Option Fund led a $30 million Series B financing on July 27 for Avila Therapeutics, which uses its proprietary Avilomics platform to design and develop covalent drugs in the areas of cancer, autoimmune disease and viral infection (read a write-up from The Pink Sheet” DAILY, here). NOF is a $200 million fund that seeds innovative companies through initial and follow-on investments – the initial investment is coupled with a program option to provide early validation of the company’s technology. Avila says it will use the proceeds to advance its first program into clinical development – its lead programs are a protease inhibitor for hepatitis C (AVL181) and a molecule targeting the Btk kinase (AVL291), an emerging target in oncology and autoimmune disease.
The Waltham, Mass.-based company did not say which of those programs would advance to clinical development first, and neither company identified the therapeutic target of the program for which NOF has option rights. Avila says its drugs work through protein-silencing – the molecules’ covalent nature enables them to bond strongly, selectively and resiliently to disease-causing proteins, theoretically producing superior therapeutic outcomes. The drug candidates’ covalent bonding also makes them effective against mutations in disease targets, according to Avila.
Participating with NOF in the Series B were Avila’s original investors – Abingworth, Advent Venture Partners, Atlas Venture and Polaris Venture Partners. The four VC firms staked Avila with $21.3 million in Series A funding in 2007, and also made a convertible debt purchase this past May that initially brought Avila $5 million and eventually could yield $15 million.
Related Articles
- First-ever covalent irreversible inhibition of a protease central to hepatitis C infection (eurekalert.org)
- Viamet Pharmaceuticals and the Novartis Option Fund Enter Agreement for Development of Novel Metalloenzyme Inhibitors (eon.businesswire.com)
- Avila Named as One of the “Fierce 15″ Biotech Companies of 2010 (eon.businesswire.com)
- Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit (xconomy.com)
- Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News (xconomy.com)
Waltham’s Care.com, online caregiver service provider, raises $20 Million October 28, 2010
Posted by hubtechinsider in Startups, Venture Capital.Tags: Care.com, Caregiver, Elderly care, Health, Home care, Matrix Partners, New Enterprise Associates, Startups, Trinity Ventures, Venture Capital, waltham
add a comment
Waltham’s Care.com, a provider of online services for finding caregivers, raises $20 Million from a group of investors led by New Enterprise Associates, Matrix Partners and Trinity Ventures.
Related Articles
- Care.com Raises $20 Million To Connect You To Nannies, Babysitters And Caregivers (techcrunch.com)
- Caregiver Search Site Care.com Raises $20 Million (paidcontent.org)
- $20M for Care.com (xconomy.com)
- Care.com Raises $20 Million in C-Round Financing Led by New Enterprise Associates (eon.businesswire.com)
Waltham’s Red Bend Software acquires Santa Clara’s VirtualLogix, for undisclosed terms October 4, 2010
Posted by hubtechinsider in Acquisitions, Startups.Tags: Acquisitions, Mobile Applications, Mobile Computing, Mobile phone, mobile software, Red Bend, Santa Clara, Startups, Telecommunication, Telecommunications, VirtualLogix, waltham
add a comment
Waltham’s Red Bend Software, a provider of mobile software management tools, acquires Santa Clara’s VirtualLogix, a provider of real-time virtualization technology for mobile handsets, for undisclosed terms.
Related Articles
- Red Bend Buys VirtualLogix (xconomy.com)
- Red Bend Buys VirtualLogix for Mobile Virtualization (pcworld.com)
- VirtualLogix Now Integrates with New ARM Processor Virtualization Links Enabling Next-Gen Mobile Devices with Advanced Functionality, Performance & Security (eon.businesswire.com)
- VirtualLogix VLX™ Virtualization Software Now Integrates with Cortex A15, Enabling Mobile Device Manufacturers to Begin Next-Gen Designs Today (eon.businesswire.com)
- ISB Corporation Chooses VirtualLogix as Partner for Accelerating Mobile and Embedded Product Development in Japan (eon.businesswire.com)
- Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News (xconomy.com)
- Infineon Technologies Selects VirtualLogix VLX Software for New Smartphone Software Architectures (eon.businesswire.com)
- Give Your Phone a Split Personality (nytimes.com)
- Give Your Phone a Split Personality (gigaom.com)
- Cortex™-A15 MPCore™ processor: ARMed to transform mobile devices (e2e.ti.com)
Waltham’s OpenPages, a developer of risk management systems, is acquired by IBM October 3, 2010
Posted by hubtechinsider in Acquisitions, Startups.Tags: Acquisitions, Goldman Sachs, IBM, Management, OpenPages, Risk management, Sigma Partners, Startups, waltham
add a comment
Waltham’s OpenPages, a developer of risk and compliance management systems, is acquired by Armonk, New York -based IBM for undisclosed terms.
In a statement, Rob Ashe, IBM’s general manager of business analytics, said: “Integrating risk management systems across once-divided units and functions is essential to seeing the bigger picture. The combination of IBM and OpenPages will provide a holistic and consistent approach to risk management helping companies combine that insight with performance management to drive better decision making.”
OpenPages is the latest IBM acquisition in Massachusetts. Last month, IBM said it was purchasing Unica Corp. of Waltham for $480 million. Over the years, IBM has scooped up more than a dozen Massachusetts businesses in such fields as data storage and security.
Related Articles
- IBM Acquires Netezza and OpenPages, Boston Scientific Buys Asthmatx, Massachusetts Startup Financing Rebounds, & More Boston-Area Deals News (xconomy.com)
- IBM Buys OpenPages To Spice Up Its Business Analytics Portfolio (techcrunch.com)
- IBM To Acquire OpenPages (informationweek.com)
- IBM picks up risk analytics provider OpenPages to stay on the safe side (venturebeat.com)
- IBM Bets on OpenPages for Its Risk-Management Offering [Voices] (voices.allthingsd.com)
- IBM Buys OpenPages To Spice Up Its Business Analytics Portfolio (Robin Wauters/TechCrunchIT) (techmeme.com)
- IBM Buys OpenPages, 17th Massachusetts Acquisition since 2003 (xconomy.com)
- IBM to acquire OpenPages (infoworld.com)
- OpenPages to Sponsor Compliance Week Webcast on the Future of Compliance (eon.businesswire.com)
- IBM Buys OpenPages To Spice Up Its Business Analytics Portfolio (techcrunchit.com)
Waltham’s ActiFio, a Disaster Recovery Solutions provider, raises $16 million in a Series A round of equity funding September 27, 2010
Posted by hubtechinsider in Startups, Venture Capital.Tags: ActiFio, Advanced Technology Ventures, Disaster recovery, Greylock Partners, North Bridge Venture Partners, Startups, Venture Capital, waltham
add a comment
Waltham’s ActiFio, a provider of data protection, disaster recovery, and business continuity solutions, raises $16 million in a Series A round of equity funding led by North Bridge Venture Partners, Advanced Technology Ventures, Netezza Corporation and Greylock Partners.
Related Articles
- ActiFio Adds $16M for Data Management (xconomy.com)
- IBM Acquires Netezza and OpenPages, Boston Scientific Buys Asthmatx, Massachusetts Startup Financing Rebounds, & More Boston-Area Deals News (xconomy.com)
- Data Management Virtualization Startup Actifio Raises $8 Million (techcrunchit.com)
- Virtualization and Disaster Recovery: Triumph over Tragedy (itexpertvoice.com)
Pyxis Mobile, the Waltham based maker of mobile applications for the financial services industry, raises $2 Million June 28, 2010
Posted by hubtechinsider in Mobile Software Applications, Startups, Venture Capital.Tags: Ascent Venture Partners, Egan Managed Capital, Mobile Applications, mobile software, Pyxis Mobile, Startups, Venture Capital, waltham
1 comment so far
Pyxis Mobile, the Waltham based maker of mobile applications for the financial services industry, raises $2 Million from a group of investors led by Ascent Venture Partners, Egan Managed Capital, and Brook Private Equity.
Related Articles
- Pyxis Mobile Selects Information Technology Industry Veteran as CEO (eon.businesswire.com)
Waltham’s Affirmed Networks, telecom technology provider, raises $10.9 MM June 27, 2010
Posted by hubtechinsider in Startups, Telecommunications, Venture Capital.Tags: Startups, Venture Capital, waltham
add a comment
Waltham’s Affirmed Networks, a developer of unspecified telecom related technologies, raises $10.9 Million (Affirmed Networks has secured $10.89 million of an $11.52 million funding round) from Charles River Ventures, at whose office the company is being incubated, and Matrix Partners. The company was founded by Sonus Networks vets Harris Fishman and Hassan Ahmed. It does not yet have a public website.
Related Articles
- Funding roundup: Affirmed Networks, Ace Metrix, HiSoft and Motricity IPOs (venturebeat.com)
- Affirmed Networks Nabs $11M (xconomy.com)
Waltham Internet security company Fidelis Security Systems raises $2.3 Million April 26, 2010
Posted by hubtechinsider in Startups, Venture Capital.Tags: Startups, Venture Capital, waltham
add a comment
Waltham Internet security company Fidelis Security Systems raises $2.3 Million from a group of undisclosed investors.
How many Massachusetts based companies are listed in the Fortune 500? April 23, 2010
Posted by hubtechinsider in Investing, Management, Manufacturing, Massachusetts High Technology, Military Contracting, Technology.Tags: boston, Cambridge, Fortune, Fortune 500, Framingham, Hopkinton, Massachusetts, Natick, Springfield, waltham
add a comment
There are 13 companies listed in this year’s Fortune 500 index of America’s largest corporations. The chart below lists all 13 Massachusetts-based companies that are in the Fortune 500, their headquarters town in Massachusetts, their rank in the Fortune 500, their 2008 revenues (in millions), and number of employees.
We can see that the 13 corporations in the Fortune 500 index of America’s largest corporations that are based in Massachusetts had combined 2008 revenues of $193 Billion dollars and employed a combined 530,000 people worldwide.
Waltham was the Massachusetts city with the most Fortune 500 company headquarters based within its borders, with three of the companies listed being based in the Watch City. Two were based in Cambridge, two in Framingham, two in Natick, two in Boston, and one each in Springfield and Hopkington.

Thirteen Massachusetts based companies are listed on the Fortune 500 index of America's largest corporations
More Articles From Boston’s Hub Tech Insider:
- Twelve Tips For Agile Project Planning and Estimating
- Eight ways to tell if your Project Team is on the Way Up, or on the Way Down
- The Twenty Laws of Testing Computer Software
- Why Designing for a VUI is harder than designing for a GUI
- The Hub Tech Insider Glossary of Mobile Web Terminology
- The Hub Tech Insider Glossary of Stock Options Terminology
- How many Stock Options should executives at a startup be granted?
- Agile Development In Practice
- What is ‘Management By Walking Around’?
- Boston Area Video Game Companies
- Demandware eCommerce
- How to expand your professional network on LinkedIn
- How to use LinkedIn in your job search
- Twitter and network effects
- How much bandwidth does a smartphone use? How much bandwidth does an Apple iPad use? How much bandwidth does an Apple iPhone use?
- What is Scrum?
- What is a “Use Case”?
- What is a “User Story”?
- What is Indirect Spend?
- What is EDIINT? What is AS2, AS1, AS3 and AS4?
Verizon to open new Waltham, Massachusetts 4G & FiOS Innovation & Research Center April 19, 2010
Posted by hubtechinsider in events, Fiber Optics, Mobile Software Applications, Telecommunications, Wireless Applications.Tags: 4G, cellular, LTE, Verizon, waltham, Wireless, Wireless Applications
1 comment so far
Verizon Communications Inc. says it plans to start building a new research center in Waltham, Massachusetts focused around 4G wireless Long Term Evolution (LTE) technology. Verizon Wireless currently is piloting an LTE network deployment in parts of Boston. The new Verizon Waltham Technology Innovation Center will eventually house more than 300 scientists and researchers, officials said, most of whom are already working for Verizon in two exisitng buildings at that location.
In addition to its LTE research, the new Waltham campus will house researchers working on other Verizon offerings. LTE is the major focus of that building, but there will also be other Verizon work going on, including the further development of FiOS.
The campus at 117 West St. in Waltham will include three buildings once the new one is finished. In addition to the research space, it will house offices, as well as an executive briefing center.
As of August 2009, Verizon had 10 LTE 4G cell sites running around Greater Boston in its pilot deployment. LTE wireless service is expected to provide up to 10 times the speed – or about 8 megabits per second – of current 3G services. In March, Verizon announced that in its pilot deployments it was seeing average speeds of between 5Mbps and 12Mbps on a download in real world use, with peaks as high as 50Mbps.
Oracle acquires Waltham’s Phase Forward for $685 Million April 18, 2010
Posted by hubtechinsider in Acquisitions, Startups.Tags: Acquisitions, Startups, Venture Capital, waltham
add a comment
The Oracle Corporation has agreed to buy Phase Forward, which makes software used to manage clinical drug trials, for $685 million, the companies said Friday. Oracle, the leading maker of database software, plans to add Phase Forward to its Health Sciences unit. Oracle is paying $17 a share in cash for Phase Forward’s stock, 30 percent more than the $13.08 closing price Thursday. Stock in Phase Forward, which is based in Waltham, Mass., rose $3.72, or 28.4 percent, to $16.80 a share. Stock in Oracle, based in Redwood City, Calif., fell 25 cents to $25.95 a share.
The Phase Forward purchase may help Oracle tap into a growing market for programs that helps make the U.S. health-care system more efficient, said Cross Research analyst Richard Williams. Oracle Chief Executive Officer Larry Ellison, 65, has spent about $42 billion buying 62 companies since January 2005.
Phase Forward delivers its software as a service over the Internet, helping researchers, physicians and regulators access and share data for clinical trials. The company’s programs have been used in more than 10,000 clinical trials by more than 300 companies and organizations, including AstraZeneca Plc, the U.S. Food and Drug Administration, and GlaxoSmithKline Plc.
Phase Forward, founded in 1997, will become part of Oracle’s Health Sciences Global business unit. Oracle, based in Redwood City, California, expects to close the deal in mid-2010.
Waltham’s Metalogix Software acquires Ann Arbor, MI -based StoragePoint April 12, 2010
Posted by hubtechinsider in Acquisitions, Startups, Venture Capital.Tags: Acquisitions, Startups, Venture Capital, waltham
add a comment
Waltham’s Metalogix Software, a provider of products for Microsoft Sharepoint migration, management, and archiving as well as Exchange migration and archiving, acquires Ann Arbor, MI -based StoragePoint, a developer of software that helps organizations to shrink their ShrePoint 2007/2010 content databases by 90% – 95%.
Newton’s Rocket Software, an IBM DB2 Database solutions provider, acquires Waltham’s Computer Corp of America April 6, 2010
Posted by hubtechinsider in Acquisitions, Startups.Tags: Acquisitions, Newton, Startups, Venture Capital, waltham
add a comment
Newton’s Rocket Software, an IBM mainframe DB2 Database solutions provider, acquires Waltham’s Computer Corp of America, a data management product developer for undisclosed terms.
Boston’s Hangout Industries, Inc., a developer of a social gaming platform, has raised $2 Million in new equity financing April 6, 2010
Posted by hubtechinsider in Gaming, Startups, Venture Capital, Video Gaming Video Games.Tags: boston, Startups, Venture Capital, Video Games, Video Gaming, waltham
add a comment
Boston’s Hangout Industries, Inc., a developer of a social gaming platform designed to run on Facebook and other social media networks, has raised $2 Million in new equity financing from Highland Capital Partners and Waltham’s Polaris Venture Partners.
Cambridge’s Allurent, an ecommerce technology company, raises $2 Million March 1, 2010
Posted by hubtechinsider in Ecommerce, Startups, Venture Capital.Tags: Cambridge, ecommerce, Startups, Venture Capital, waltham
add a comment
Cambridge’s Allurent, an ecommerce technology company, raises $2 Million in a Series C round of equity capital from Waltham’s Polaris Venture Partners.































































